Thompson Siegel & Walmsley Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FINL
Finish Line
FINL
|
+$40M |
| 2 |
SCG
Scana
SCG
|
+$34.7M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$26.6M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$22.7M |
| 5 |
Copa Holdings
CPA
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BWX Technologies
BWXT
|
+$31.8M |
| 2 |
Madison Square Garden
MSGS
|
+$25M |
| 3 |
WR
Westar Energy Inc
WR
|
+$22.4M |
| 4 |
Alaska Air
ALK
|
+$20.8M |
| 5 |
NSR
Neustar Inc
NSR
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Utilities | 13.05% |
| 3 | Technology | 11.74% |
| 4 | Industrials | 9.14% |
| 5 | Healthcare | 8.17% |
Similar funds
Thompson Siegel & Walmsley's Q3 2015 Portfolio in Review
As of Q3 2015, Thompson Siegel & Walmsley held 742 positions worth $5.37B, down 4.8% from $5.64B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Thompson Siegel & Walmsley deployed $217M of net new capital in Q3 2015, opening 46 new positions and adding to 177 existing holdings. Its largest new stake was Finish Line: 1,510,085 shares worth $29.1M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Utilities and Technology.
On the sell side, the largest reduction was BWX Technologies, an estimated $31.8M trimmed.
- Thompson Siegel & Walmsley's largest Q3 2015 buy was Finish Line: 1,510,085 shares worth $29.1M.
- Thompson Siegel & Walmsley added most to Scana in Q3 2015, an estimated $34.7M increase.
- Thompson Siegel & Walmsley's biggest Q3 2015 reduction was BWX Technologies, cutting an estimated $31.8M.
- Thompson Siegel & Walmsley fully exited Madison Square Garden in Q3 2015, selling an estimated $25M.
- Thompson Siegel & Walmsley's ten largest holdings make up 13% of its $5.37B portfolio in Q3 2015.
- Thompson Siegel & Walmsley opened 46 new positions and closed 38 in Q3 2015.
- Thompson Siegel & Walmsley's portfolio value fell 4.8% quarter-over-quarter to $5.37B.
Based on Thompson Siegel & Walmsley's 13F filing for Q3 2015, filed 3 Nov 2015.